应用GRASP MRI评估肝脏灌注:将肝脏MRI提升至新水平
本研究前瞻性纳入10例肝细胞癌患者,在经动脉化疗栓塞(TACE)前后行动态对比增强(DCE)GRASP MRI,并与TACE前体积灌注CT(VPCT)对比。结果显示DCE GRASP MRI可可靠生成灌注图,灌注参数与VPCT处于相同绝对范围,且TACE后靶病灶动脉肝灌注和肝灌注指数显著下降(P≤0.01)。
要点
- DCE GRASP MRI灌注图在全部数据中成功生成,观察者间ICC≥0.88(P≤0.001)。
- DCE MRI与VPCT的肿瘤及肝组织灌注参数处于相同绝对范围。
- TACE后靶病灶动脉肝灌注和肝灌注指数显著下降(P≤0.01)。
核心结论
- DCE GRASP MRI可可靠、稳健地评估肝脏灌注参数,定量结果与VPCT相当,并能表征TACE前后的HCC,可能作为VPCT的替代方法。
研究设计与样本
- 前瞻性、机构审查委员会批准的研究,2017年11月至2018年9月纳入10例HCC患者(男性8例;平均年龄66.5±8.6岁),所有患者TACE前后行DCE GRASP MRI(注射肝脏特异性MR对比剂后),TACE前另行VPCT作为参考标准。
诊断标准与关键数值
- 采用双输入最大斜率模型计算灌注图:动脉肝灌注(mL/100 mL/min)、门静脉肝灌注(mL/100 mL/min)、肝灌注指数(%);观察者间一致性ICC≥0.88(P≤0.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to demonstrate the feasibility of hepatic perfusion imaging using dynamic contrast-enhanced (DCE) golden-angle radial sparse parallel (GRASP) magnetic resonance imaging (MRI) for characterizing liver parenchyma and hepatocellular carcinoma (HCC) before and after transarterial chemoembolization (TACE) as a potential alternative to volume perfusion computed tomography (VPCT).
METHODS AND MATERIALS: Between November 2017 and September 2018, 10 patients (male = 8; mean age, 66.5 ± 8.6 years) with HCC were included in this prospective, institutional review board-approved study. All patients underwent DCE GRASP MRI with high spatiotemporal resolution after injection of liver-specific MR contrast agent before and after TACE. In addition, VPCT was acquired before TACE serving as standard of reference. From the dynamic imaging data of DCE MRI and VPCT, perfusion maps (arterial liver perfusion [mL/100 mL/min], portal liver perfusion [mL/100 mL/min], hepatic perfusion index [%]) were calculated using a dual-input maximum slope model and compared with assess perfusion measures, lesion characteristics, and treatment response using Wilcoxon signed-rank test. To evaluate interreader agreement for measurement repeatability, the interclass correlation coefficient (ICC) was calculated.
RESULTS: Perfusion maps could be successfully generated from all DCE MRI and VPCT data. The ICC was excellent for all perfusion maps (ICC ≥ 0.88; P ≤ 0.001). Image analyses revealed perfusion parameters for DCE MRI and VPCT within the same absolute range for tumor and liver tissue. Dynamic contrast-enhanced MRI further enabled quantitative assessment of treatment response showing a significant decrease (P ≤ 0.01) of arterial liver perfusion and hepatic perfusion index in the target lesion after TACE.
CONCLUSIONS: Dynamic contrast-enhanced GRASP MRI allows for a reliable and robust assessment of hepatic perfusion parameters providing quantitative results comparable to VPCT and enables characterization of HCC before and after TACE, thus posing the potential to serve as an alternative to VPCT.
引用
- Weiss J, Ruff C, Grosse U, et al. Assessment of Hepatic Perfusion Using GRASP MRI: Bringing Liver MRI on a New Level. Invest Radiol. 2019. PMID: 31206392. doi:10.1097/RLI.0000000000000586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。